A Study to Test How Well Healthy Men Tolerate BI 765250 When Given as an Infusion Into the Vein or as an Injection Under the Skin
NCT05151653 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 139
Last updated 2025-01-22
Summary
The main objectives of this trial are to investigate safety, tolerability, pharmacokinetics and pharmacodynamics following single rising doses of BI 765250.
Conditions
- Healthy
Interventions
- DRUG
-
BI 765250
BI 765250
- DRUG
-
Placebo
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-01-26
- Primary Completion
- 2024-09-13
- Completion
- 2024-09-13
Countries
- Belgium
Study Locations
More Related Trials
-
A Study to Test How Well Different Doses of BI 1815368 Are Tolerated by Healthy Men
NCT05857878 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Men Tests How Different Doses of BI 764198 Are Taken up in the Body and How Well They Are Tolerated.
NCT03854552 ·Status: COMPLETED ·Phase: PHASE1
-
This Study Tests How Healthy Men Tolerate Different Doses of BI1015550. The Study Also Tests How BI 1015550 is Taken up by the Body
NCT03230487 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses of BI 1015550 in Healthy Male Volunteers
NCT01594515 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Test How Well Different Doses of BI 3810477 Are Tolerated by Healthy Men
NCT06631430 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy People to Measure the Amount of BI 655130 in the Blood After Injecting Different Doses Into Different Parts of the Body
NCT03617835 ·Status: COMPLETED ·Phase: PHASE1
-
Single Rising Dose Study of BI 655088 Administered Intravenously in Healthy Male Volunteers
NCT02696616 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Men to Test How Different Doses of BI 1815368 Are Tolerated and How BI 1815368 is Taken up in the Body With or Without Food
NCT05337592 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Men to Test How BI 1595043 is Taken up in the Body When Given With or Without Food
NCT04789291 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
NCT05515328 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Rising Oral Doses and Multiple Rising Oral Doses of BI 1356 BS in Healthy Male Volunteers
NCT02183311 ·Status: COMPLETED ·Phase: PHASE1
-
Single Rising Dose Study (Intravenous Infusion and Subcutaneous Injection) of BI 655064 in Healthy Male Volunteers
NCT01510782 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
NCT04065295 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Men to Test How BI 1291583 is Taken up by the Body
NCT06166992 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Doses of BI 1356 BS in Healthy Male Volunteers
NCT02183298 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Oral Doses of BI 1356 BS Administered to Healthy Male Subjects
NCT02173665 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Men to Test How BI 1015550 is Taken up and Handled by the Body
NCT05707403 ·Status: COMPLETED ·Phase: PHASE1
-
To Investigate the Safety, Tolerability, Pharmacokinetics and the Relative Bioavailability of BI 1026706
NCT01763333 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Men to Test How Well Different Doses of BI 3731579 Are Tolerated
NCT06429137 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, and Pharmacokinetics of a Subcutaneous and Intravenous Dose of BI 655130 in Healthy Subjects
NCT03100903 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Test How Well Different Doses of BI 3804379 Are Tolerated by Healthy People
NCT06575400 ·Status: RECRUITING ·Phase: PHASE1
-
Safety and Tolerability of BI 638683 After Single Rising Oral Doses in Healthy Male Subjects
NCT01195688 ·Status: COMPLETED ·Phase: PHASE1
-
This Study in Healthy Men Tests How Different Doses of BI 894416 Are Taken up in the Body and How Well BI 894416 is Tolerated
NCT03315936 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Men to Find Out How Well Different Doses of BI 764122 Are Tolerated and Whether Food Affects the Amount of BI 764122 in the Blood
NCT03794323 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability and Pharmacokinetics of Single Rising Intravenous Doses of BI 44370 BS Solution in Healthy Male Volunteers
NCT02215031 ·Status: COMPLETED ·Phase: PHASE1